Orexo AB Cash Flow Conversion Efficiency

Latest as of June 2026: -0.344x

Orexo AB cash flow conversion efficiency. Based on the latest financial reports, Orexo AB (ORX) has a cash flow conversion efficiency ratio of -0.344x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-93.30 Million ≈ $-10.04 Million USD) by net assets (Skr271.30 Million ≈ $29.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Orexo AB (2002–2025)

Cash flow conversion efficiency of Orexo AB from 2002 to 2025. This chart illustrates how Orexo AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Orexo AB stock quote for real-time trading data and today's change.

Orexo AB Cash Flow Conversion Ratio Explained

Orexo AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Orexo AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orexo AB ranked by their cash flow conversion efficiency. Also see ORX market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Homebiogas Ltd TA:HMGS	-0.172x
Westbond Enterprises Corp V:WBE	0.025x
Garanti Yatirim Ortakligi AS IS:GRNYO	0.026x
NCC Group plc LSE:NCC	0.124x
Nanologica AB ST:NICA	-0.064x
Hiremii Ltd AU:HMI	-0.436x
Utilico Emerging Markets Ltd LSE:UEM	0.009x
ECS Botanics Holdings Ltd AU:ECS	0.015x

Annual Cash Flow Conversion Efficiency for Orexo AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Orexo AB from 2002 to 2025. Review ORX FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr490.60 Million ≈ $52.80 Million	Skr173.00 Million ≈ $18.62 Million	0.353x	+36.20%
2024-12-31	Skr-126.30 Million ≈ $-13.59 Million	Skr-32.70 Million ≈ $-3.52 Million	0.259x	+116.05%
2023-12-31	Skr58.90 Million ≈ $6.34 Million	Skr-95.00 Million ≈ $-10.22 Million	-1.613x	-99.71%
2022-12-31	Skr193.90 Million ≈ $20.87 Million	Skr-156.60 Million ≈ $-16.85 Million	-0.808x	-23.30%
2021-12-31	Skr349.60 Million ≈ $37.62 Million	Skr-229.00 Million ≈ $-24.64 Million	-0.655x	-2277.60%
2020-12-31	Skr558.50 Million ≈ $60.10 Million	Skr16.80 Million ≈ $1.81 Million	0.030x	-92.60%
2019-12-31	Skr706.40 Million ≈ $76.02 Million	Skr287.00 Million ≈ $30.89 Million	0.406x	-20.07%
2018-12-31	Skr476.10 Million ≈ $51.24 Million	Skr242.00 Million ≈ $26.04 Million	0.508x	+14.11%
2017-12-31	Skr329.10 Million ≈ $35.42 Million	Skr146.60 Million ≈ $15.78 Million	0.445x	-11.51%
2016-12-31	Skr310.30 Million ≈ $33.39 Million	Skr156.20 Million ≈ $16.81 Million	0.503x	+231.25%
2015-12-31	Skr266.46 Million ≈ $28.68 Million	Skr-102.19 Million ≈ $-11.00 Million	-0.384x	+64.19%
2014-12-31	Skr455.02 Million ≈ $48.97 Million	Skr-487.30 Million ≈ $-52.44 Million	-1.071x	+34.30%
2013-12-31	Skr161.46 Million ≈ $17.38 Million	Skr-263.20 Million ≈ $-28.32 Million	-1.630x	-1187.18%
2012-12-31	Skr191.19 Million ≈ $20.58 Million	Skr28.67 Million ≈ $3.09 Million	0.150x	+139.79%
2011-12-31	Skr311.10 Million ≈ $33.48 Million	Skr-117.23 Million ≈ $-12.62 Million	-0.377x	-310.64%
2010-12-31	Skr468.24 Million ≈ $50.39 Million	Skr-42.97 Million ≈ $-4.62 Million	-0.092x	+62.41%
2009-12-31	Skr548.66 Million ≈ $59.04 Million	Skr-133.93 Million ≈ $-14.41 Million	-0.244x	-37.04%
2008-12-31	Skr569.78 Million ≈ $61.32 Million	Skr-101.49 Million ≈ $-10.92 Million	-0.178x	+25.50%
2007-12-31	Skr671.25 Million ≈ $72.24 Million	Skr-160.49 Million ≈ $-17.27 Million	-0.239x	-206.76%
2006-12-31	Skr324.35 Million ≈ $34.91 Million	Skr-25.28 Million ≈ $-2.72 Million	-0.078x	+41.80%
2005-12-31	Skr338.91 Million ≈ $36.47 Million	Skr-45.38 Million ≈ $-4.88 Million	-0.134x	+33.29%
2004-12-31	Skr79.44 Million ≈ $8.55 Million	Skr-15.94 Million ≈ $-1.72 Million	-0.201x	+73.90%
2003-12-31	Skr35.88 Million ≈ $3.86 Million	Skr-27.59 Million ≈ $-2.97 Million	-0.769x	+5.68%
2002-12-31	Skr25.52 Million ≈ $2.75 Million	Skr-20.80 Million ≈ $-2.24 Million	-0.815x	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$5.66 Million

Skr52.62 Million SEK

Market Cap Rank

#28257 Global

#619 in Sweden

Share Price

Skr1.50

Change (1 day)

-64.38%

52-Week Range

Skr1.50 - Skr35.75

All Time High

Skr85.70